Skip to search.
 FTSE 100 Down 0.04%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
413.84 Down 6.03(1.44%) 21:00
|After Hours: : 414.01 Up 0.16 (0.04%) 21:13 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:419.87
Open:421.04
Bid:413.48 x 300
Ask:414.40 x 900
1y Target Est:444.45
Beta:0.93
Earnings Date:6 May - 11 May (Est.)
Day's Range:411.04 - 421.07
52wk Range:269.50 - 437.64
Volume:777,205
Avg Vol (3m):819,782
Market Cap:42.16b
P/E (ttm):134.80
EPS (ttm):3.07
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 1.44%42.16b
AMGNDown 0.79%119.69b
NVSDown 0.54%245.72b
RHHBYUp 0.80%N/A

Key Statistics

Forward P/E (1 yr):33.59
P/S (ttm):15.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :10.74
Quarterly EPS Est (Mar-15) :2.70
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback